Latest Share Chat

REMOVE ADS

Syncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes

Get Live Data

95.40 -0.80 (-0.83%)

Bid:

96.00

Ask:

96.80

Spread: 0.80 (0.833%)

Market Cap: £580.22m

Last checked at -

Intraday Syncona Share Chart

REMOVE ADS

Syncona News

Syncona portfolio firm Autolus Therapeutics widens quarterly loss

(Alliance News) - Syncona Ltd on Thursday noted that its portfolio company Autolus Therapeutics PLC had widened its third quarter loss as it continued...

Syncona to acquire retinal therapy firm Applied Genetic Technologies

(Alliance News) - Syncona Ltd on Monday it will expand its retinal gene therapy pipeline with the acquisition of a Florida-based biotechnology company...

Syncona to buy US biotech AGTC for $23.5m

(Sharecast News) - Healthcare group Syncona said on Monday that it has agreed to buy US biotechnology firm Applied Genetic Technologies Corporation (A...

Syncona confident after Q1 market volatility

(Sharecast News) - Healthcare investor Syncona reported net assets of £1.33bn at the end of its first quarter on Tuesday, or 197.9p per share, up...

IN BRIEF: Syncona posts slight quarterly NAV rise on foreign exchange

Syncona Ltd - London-based investor in healthcare companies - Reports small quarterly net asset value rise on gain on foreign exchange. Net asset valu...

Syncona notes half-year results and studies of Freeline and Achilles

(Alliance News) - Syncona Ltd on Tuesday noted half-year results of its investees, Freeline Therapeutics Holdings PLC and Achilles Therapeutics PLC.

UK shareholder meetings calendar - next 7 days

Syncona investee Freeline's gene therapy for haemophilia B tolerated

(Alliance News) - Syncona Ltd on Monday said investee Freeline Therapeutics Holdings PLC has presented partial safety and efficacy data from a phase I...